Original Article

Journal of Investigative Dermatology (1994) 103, 669–673; doi:10.1111/1523-1747.ep12398454

Th2 Cytokine mRNA Expression in Skin in Cutaneous T-Cell Lymphoma

Benjamin R Vowels, Stuart R Lessin, Maureen Cassin, Christine Jaworsky, Bernice Benoit, Jonathan T Wolfe and Alain H Rook

The Cutaneous T Cell Lymphoma Group, Department of Dermatology, University of Pennsylvania, School of Medicine, Philadelphia, Pennsylvania, U.S.A.

Received 1 March 1994; Revised 6 June 1994; Accepted 12 June 1994.

Top

Abstract

We have previously demonstrated that peripheral blood mononuclear cells from patients with Sézary syndrome, the leukemic form of cutaneous T-cell lymphoma which is accompanied by erythroderma and lymphadenopathy, have a Th2 cell cytokine [interleukin 4 (IL-4) and interleukin 5] production pattern. In this study, we extend these observations to demonstrate a correlation of the presence of a Th2 cytokine pattern with a malignant T-cell clone in different stages of cutaneous involvement among patients with cutaneous T-cell lymphoma (CTCL). Skin biopsies were obtained from 12 CTCL patients with various disease stages (three patch, three plaque, six tumor), three patients with parapsoriasis, four patients with inflammatory dermatoses, including two psoriasis and two lichen planus, and 12 normal controls. Total RNA was extracted, reverse transcribed, and PCR amplified with IL-2, IL-4, IL-5. interferon gamma (IFN-gamma, and beta-actin oligonucleotide primers. Although all skin specimens tested had detectable IL-2 and IFN-gamma mRNA, only specimens from patients with CTCL or parapsoriasis had demonstrable IL-4 and/or IL-5 mRNA. Specifically, IL-5 mRNA was detected in skin biopsies from five of six tumor-stage CTCL, two of three plaque-stage CTCL, one of three patch-stage CTCL, and 1 of 3 parapsoriasis patients, whereas IL-4 mRNA was demonstrated to be present in five of six tumor-stage, one of three plaque stage, none of three patch-stage CTCL, and none of three parapsoriasis patients. These results indicate that in all stages of cutaneous involvement of CTCL, encompassing patch stage through tumor stage, IL-4 and IL-5 mRNA is variably detectable. In tumor-stage skin lesions, typically characterized by a dense dermal infiltrate of malignant T cells, Th2 cytokine mRNA is virtually always detectable. The ability to detect Th2 cytokine mRNA in the skin of patients with CTCL supports our previous findings that the malignant T cells in CTCL posses a Th2-helper cell phenotype.

Keywords:

Sézary syndrome, interleukin, mononuclear leukocytes, skin neoplasms

Top

References

  1. Mosmann, TR, Cherwinski, H, Bond, MW, Giedlen, MA, Coffman, RL: Two types of murine helper T cell clone. I. Definition according to profiles of lymphokinc activities and secreted proteins. J Immunol 136: 2348–2357, 1986 | PubMed | ISI | ChemPort |
  2. Fiorentine, DF, Bond, MW, Mosmann, TR: Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 170: 2081–2089, 1989
  3. Mosmann, TR, Coffman, RL: TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 7: 145–173, 1989 | Article | ISI | ChemPort |
  4. Romagnani, S: Human Th1 and Th2 subsets: doubt no more. Immunol Today 12: 256–257, 1991 | Article | PubMed | ISI | ChemPort |
  5. Rotteveel, FTM, Kokkelink, I, van Lier, RAW, Kuenen, B, Meager, A, Miedema, F, Lucas, CJ: Clonal analysis of functionally distinct human CD4+ T cell subsets. J Exp Med 168: 1659–1673, 1988
  6. Jabara, HH, Ackerman, SJ, Vercelli, D, Yokota, T, Arai, K, Abrams, J, Dvorak, AM, Lavigne, MC, Banchereau, J, DeVries, J, Leung, DYM, Geha, RS: Induction of interleukin-4-dependent IgE synthesis and interleukin-5- dependent eosinophil differentiation by supernatants of a human helper T-cell clone. J Clin Immunol 8: 437–446, 1988
  7. Parronchi, P, Macchia, D, Piccinni, M-P, Biswas, P, Simonelli, C, Maggi, E, Ricci, M, Ansari, AA, Romagnani, S: Allergen-and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc Natl Acad Sci USA 88: 4538–4542, 1991 | PubMed | ChemPort |
  8. Wierenga, EA, Snoek, M, DeGroot, C, Chretien, I, Bos, JD, Jansen, HM, Kapsenberg, ML: Evidence for compartmentalization of functional subsets of CD4+ lymphocytes in atopic patients. J Immunol 144: 4651–4656, 1990 | PubMed | ISI | ChemPort |
  9. Robinson, DS, Hamid, Q, Ying, S, Tsicopoulos, A, Barkans, J, Bentley, AM, Corrigan, C, Durham, SR, Kay, AB: Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 326: 298–304, 1992 | PubMed | ISI | ChemPort |
  10. Yamamura, M, Uyemura, K, Deans, RJ, Weinberg, K, Rea, TH, Bloom, BR, Modlin, RL: Denning protective responses to pathogens: cytokine profiles in leprosy lesions. Science 254: 277–279, 1991 | PubMed | ISI | ChemPort |
  11. Del Prete, G: Human Th1 and Th2 lymphocytes: their role in the pathophysiology of atopy. Allergy 47: 450–455, 1992 | PubMed | ChemPort |
  12. Goldman, M, Druet, P, Gleichman, E: Th2 cells in systemic autoimmunity: insights from allogeneic disease and chemically-induced autoimmunity. Immunol Today 12: 223–227, 1991 | Article | PubMed | ISI | ChemPort |
  13. Rook, AH, Lessin, SR, Jaworsky, C, Singh, A, Vowels, BR: The immunopathogenesis of cutaneous T cell lymphoma: abnormal cytokine production by Sezary T-cells. Arch Dermatol 129: 486–489, 1993 | Article | PubMed | ISI | ChemPort |
  14. Vowels, BR, Cassin, M, Vonderheid, E, Rook, AH: Aberrant cytokine production by Sezary syndrome patients: cytokine secretion pattern resembles murine Th2 cells. J Invest Dermatol 99: 90–94, 1992 | Article | PubMed | ISI | ChemPort |
  15. Murphy, GF: Cutaneous T cell lymphoma. Adv Pathol 1: 131–156, 1988
  16. Sambrook, J, Fritsch, EF, Maniatis, I: Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Springs Harbor Laboratory, Cold Spring Harbor, New York, 1981
  17. Lessin, SR, Rook, AH, Rovera, G: Molecular diagnosis of cutaneous T-cell lymphoma: polymerase chain reaction amplification of T-cell antigen receptor beta-chain gene rearrangements. J Invest Dermatol 96: 299–302, 1991
  18. Hillier, L, Green, P: OSP: A computer program for choosing PCR and DNA sequencing primers. PCR Methods Appl 1: 124–128, 1991 | PubMed | ChemPort |
  19. Lambert, WC, Everett, MA: The nosology of parapsoriasis. J Am Acad Dermatol 5: 373–395, 1981
  20. Bos, JD, Zonneveld, I, Doss, PK, Kreig, ST, VanderLoos, CM, Kapsenberg, ML: The skin immune system: distribution and immunophenotype of lymphocyte subpopulations in normal human skin. J Invest Dermatol 88: 569–573, 1987 | Article | PubMed | ISI | ChemPort |
  21. Ullman, KS, Northrup, JP, Verweij, CL, Crabtree, GR: Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link. Annu Rev Immunol 8: 421–452, 1990 | Article | PubMed | ISI | ChemPort |
  22. Dummer, R, Kohl, O, Gillessen, J, Kagi, M, Burg, G: Peripheral blood mononuclear cells in patients with nonleukemic cutaneous T-cell lymphoma: reduced proliferation and preferential secretion of a T helper-2-like cytokine pattern. Arch Dermatol 129: 433–436, 1993 | Article | PubMed | ISI | ChemPort |
  23. Bradding, P, Feather, IH, Howarth, PH, Mucller, R, Roberts, JA, Britten, K, Bews, J, Hunt, TC, Okayama, Y, Heusser, CH: Interleukin 4 is localized to and released by human mast cells. J Exp Med 176: 1381–1386, 1992 | Article | PubMed | ISI | ChemPort |
  24. Broide, DH, Paine, MM, Firestein, GS: Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics. J Clin Invest 90: 1414–1424, 1992 | PubMed | ChemPort |
  25. Peleman, R, Wu, J, Rargeas, C, Delespesse, G: Recombinant interleukin 4 suppresses the production of interferon gamma by human mononuclear cells. J Exp Med 170: 1751–1756, 1989 | Article | PubMed | ChemPort |
  26. Wood, GS, Edinger, A, Hoppe, RT, Warnke, RA: Mycosis fungoides skin lesions contain CD8+ tumor-infiltrating lymphocytes expressing an activated, MHC-restricted cytotoxic T lymphocyte phenotype. J Cutan Pathol 21: 151–156, 1994 | PubMed | ISI | ChemPort |
  27. Salmeron, AU, Morita, T, Seki, H, Platsoucas, CD, Itoh, K: Lymphokine production by human melanoma tumor-infiltrating lymphocytes. Cancer Immunol Immunother 35: 211–217, 1992
  28. Griffiths, CEM, Voorhees, JJ, Nickoloff, BJ: Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor. J Am Acad Dermatol 20: 617–629, 1989 | PubMed | ISI | ChemPort |
  29. Kaplan, EH, Rosen, ST, Norris, DB, Roenigk, HH, Saks, SR, Bunn, PA: Phase II study of recombinant human interferon gamma for treatment of cutaneous T-cell lymphoma. J Natl Cancer Inst 82: 208–212, 1990 | PubMed |
  30. Brinkmann, V, Geiger, T, Alkan, S, Heusser, CH: Interferon alfa increases the frequency of interferon gamma producing human CD4+ T cells. J Exp Med 178: 1655–1663, 1993 | Article | PubMed | ISI | ChemPort |
  31. Olsen, EA, Rosen, ST, Vollmer, RT, Variakojis, D, Roenigk, HH, Diab, N, Zeffren, J: Interferon alfa-2a in the treatment of cutaneous T-cell lymphoma. J Am Acad Dermatol 20: 395–407, 1989
  32. Soiffer, RJ, Robertson, MJ, Murray, C, Cochran, K, Ritz, J: Interleukin-12 augments cytolytic activity of peripeheral blood lymphocytes from patients with hematologie and solid malignancies. Blood 82: 2790–2796, 1993 | PubMed | ISI | ChemPort |

Extra navigation

.
ADVERTISEMENT